Abstract: This research employs multiple linear regressions to explore the impacts of intellectual capital on corporate performance of biotechnology and pharmaceutical firms from perspective of multimedia data applications in Taiwan. We divided multimedia data of intellectual capital into four main components: human capital, process capital, innovation capital, and customer capital. The sample includes companies listed in Taiwan Stock Exchange (TSE) and Taipei exchange market for the period 2007 to 2013. The results show that the association between innovation capital and performance is positive. The human capital and process capital partially improve firms' performance while customer capital did not significantly improve the accounting performance. The results suggest the role of intellectual capital and innovation capital in enhancing the financial performance of companies in biotechnology and pharmaceutical industry. From the web-scale experience, the finding serves as valuable information for investors while making investment decisions.
Introduction
In the new knowledge economy, intellectual capital is widely considered as the most important source of competitive advantage and also the key resource for enterprises to obtain profits in the last two decades. Intellectual capital in new economy era gradually replaces land, capital and materials and becomes important sources to create firm value. A number of research in the area of biotechnology and pharmaceutical (Hermans and Kauranen, 2005; Pal and Soriya, 2012) have found a positive relationship between intellectual capital and firm performance. The purpose of this study is to investigate the impacts of intellectual capital (human capital, process capital, innovation capital, and customer capital) on firm performance in biotechnology and pharmaceutical firms in Taiwan.
In recent years, firms in intelligence and knowledge intensive industry create higher market value by intellectual capital. For pharmaceutical industry, there can be the differences of at least ten times. Hence, in new economy era, enterprises' capacity to control and use intangible assets such as employees' skills, research and development (R&D), innovation and business process becomes critical of corporate competitiveness. According to the 'Taiwan Pharmaceuticals and Healthcare Report Q2 2015' from market research.com, pharmaceuticals expenditure is TWD167.74bn (USD5.53bn) and TWD175.07bn (USD5.56bn) in 2014 and 2015, respectively.
Many literatures suggested that intellectual capital is the factor to drive and create corporate value and it positively influences corporate performance (Kaplan and Norton, 1992; Edvinsson and Malone, 1997; Ittner et al., 1997; Stewart, 1997) . They found that intellectual capital leads to competitive advantages for enterprises, and increases corporate value. It is the most valuable asset and useful tool of competition. The main issue proposed to be addressed in this research is to investigate how human capital, process capital, innovation capital and customer capital affect financial performance of firms. The results show that the association between innovation capital and performance is positive. The human capital and process capital partially improve firms' performance while customer capital did not significantly improve the accounting performance. The results suggest the role of intellectual capital and innovation capital in enhancing the financial performance of companies in biotechnology and pharmaceutical industry. The contributions of this research are as follows. First, we use the multimedia data of intellectual capital. The finding may serves as valuable information for investors to make investment decision. Second, we choose the biotechnology and medicine industry, which has been greatly enhanced by government's concentrated policy since 2007 in Taiwan.
The structure of this study is organised as follows. Section 2 reviews the related literature of intellectual capital and develops the four hypotheses. Section 3 describes my research sample, variables and methodology. Section 4 reports and analyses the results. Section 5 gives summary.
Literature review and hypothesis development

The concept and definition of intellectual capital
Intellectual capital was originally proposed by Galbraith (1969) . Figure 1 represents the intellectual capital framework of Skandia's value scheme (Roos et al., 1997) . As shown in Figure 1 , intellectual capital is the sum of human capital and structural capital. Structural capital also included customer capital and organisation capital. Edvinsson and Malone (1997) recommended 112 metrics to measure five areas (financial focus; customer focus; process focus; renewal and development focus, and human focus) of the navigator model. These metrics are summarised as shown in Table 1 . Table 1 Sample of Skandia IC measures
Financial focus
• Revenues/employee ($)
• Revenues from new customers/total revenue ($)
• Profits resulting from new business operations ($)
Customer focus • Days spent visiting customers (#)
• Ratio of sales contacts to sales closed (%)
• Number of customers gained versus lost (%)
Process focus
• PCs/employee (#)
• IT capacity -CPU (#)
• Processing time (#)
Renewal and development focus • Satisfied employee index (#)
• Training expense/administrative expense (%)
• Average age of patents (#)
Human focus • Managers with advanced degrees (%)
• Annual age of patents (#)
• Leadership index (%)
Source: Bontis (2001) Figure 1 Intellectual capital value scheme of Skandia Source: Roos et al. (1997) Intellectual capital is composed of three main components: human capital, organisational capital and relational capital (Edvinsson and Malone, 1997) . According to Edvinsson and Malone (1997) , organisational capital can be divided into process capital and innovation capital. In this study, we assume intellectual capital is composed of four main components: human capital, process capital, innovation and customer capital. Human capital includes creativity, knowledge, skills, education, experiences and competence. Organisational (structural) capital refers to the stock of knowledge that is expressed on paper. It remains as possession and is controlled by the company. This includes databases, brands, culture, software, copyrights, processes, management information systems, strategies and other resources that carry higher value than their material value (Roos et al., 2005) . Relational capital refers to all intangibles that develop over time between a company and the external groups such as marketing channels, customer relationships, and relationships with suppliers, customer loyalty, governmental and industrial networking, partners, lenders, market intelligence, customer satisfaction and reputation (Tayles et al., 2002) .
Intellectual capital and firm performance
According to research findings of Hall (1993) and Chauvin and Hirschey (1993) , R&D expenditure and corporate performance have significant and positive correlation with market value. Sougiannis (1994) treated 573 large-scale enterprises in the USA from 1975 to 1985 as samples and probed into effect of R&D expenditure on long-term profits and market value of enterprises. Lev and Sougiannis (1996) tried to find if R&D expenditure of enterprises has delay effect on future profits and if capital of R&D expenditure increases stock prices and profits. According to the findings, capitalisation of R&D expenditure enhances explained power of stock price and profits. Human capital is an intangible asset and can be defined as skills and expertise, ability for solving problem, leadership styles and abilities owned by employees (Stewart, 1997; Dzinkowski, 2000) . It incorporates knowledge, expertise, innovation and employee's ability to handle their jobs; it also includes the firm's culture and philosophy. Studies found human capital is positively associated with firms' financial performance (Ling and Jaw, 2006; Scafarto et al., 2016; Singh and Narwal, 2016) . The innovation will occur based on the better systems of a firm (Subramaniam and Youndt, 2005) . Process capital will increase customer satisfaction and competitiveness (Ling and Jaw, 2006) . Many studies have found that relation capital (customer capital) has an effect on firms' profit and increase market share (Narver and Slater, 1990) . Customer capital can increase a firm's innovation breakthroughs (Ojeda-Gomez et al., 2007; Spencer, 2003) . In accordance with the aforementioned literatures and discussion, the hypotheses are proposed as follows:
Hypothesis 1 Human capital is positively associated with firm performance.
Hypothesis 2 Process capital is positively associated with firm performance.
Hypothesis 3 Innovation capital is positively associated with firm performance.
Hypothesis 4 Customer capital is positively associated with firm performance.
Research methodology
From perspective of multimedia data applications, this study employs a multiple linear regression model to test the relationship between four components of intellectual capital and firm financial performance of biotechnology and pharmaceutical companies in Taiwan. We define the meanings of variables, indicating the analysis methods.
Sample and data
This research was carried out from 2007 to 2013 on 825 firm year observations from biotechnology and pharmaceutical firms listed on Taiwan Stock Exchange (TSE) and Taipei Exchange Market. Other data of this research were collected from the Taiwan Economic Journal (TEJ) database and market observation post system (MOPS).
Empirical model
The main purpose of this research is to discuss the relationship between intellectual capital and firm performance. There are different methodologies to measure performance (Vladimir, 2010; Dimaki et al., 2011; Koyama et al., 2010; Zhou et al., 2014) . For this research, we choose return on assets (RA) and return on equity (RE) as a dependent variable to measure accounting firm performance. These two indicators are considered as one of the most common used indicator in intellectual capital. RA is a profitability ratio that measures the net revenue produced by total average assets during a calendar year. RE is also a profitability ratio that measures the net revenue produced by average shareholder's equity during a calendar year.
We divided the independent variables into four parts: human capital variables included employee productivity, operating revenue per employee (ORPE) and employee added value; process capital variables included management fee ratio, management fee per person, fixed assets turnover (FAT) and total assets turnover; innovation capital variables included R&D intensity, R&D productivity (RDP) and R&D expense; customer capital variables included sales expense rate, product accept rate (PAR) and operating revenue growth rate. The control variables are size, debt ratio (Dr), sales growth rate (Sgw), advertising (Adv), inventory turnover ratio (Invtr), and gross profit margin (Gropm). The empirical models used in our study are as follows:
Equation (1) tests the association between human capital and firm performance. We use employee productivity (EP), ORPE and employee added value (EAV) as proxies for human capital.
( )
Equation (2) tests the association between process capital and firm performance. We use management fee ratio (MFR), management fee per person (MFP), FAT and total assets turnover (TAT) as proxies for process capital.
( ) 
The operational definitions of all the variables are described in Table 2 . Tables 4 through 7 present the Pearson correlation between the variables used in regressions (1) through (4). Table 8 represents the results of regression (1) that is the relationship between human capital and firm performance. The coefficient of ORPE is statistically significant for RA (0.094, p = 0.015) and RE (0.181, p = 0.015). The coefficient of EAV is statistically significant for RA (0.242, p = 0.000) and RE (0.33, p = 0.15). The results implies that an increase of revenue per employee by 1 unit leads to an increase in firm performance by 0.094 RA and 0.181 RE units. An increase of EAV by 1 unit leads to an increase in firm performance by 0.242 RA and 0.33 RE units. The coefficient of EP is statistically significant for RA (-0.087, p = 0.000) and RE (-0.132, p = 0.001), but the coefficient is negative. The other control variables are partially significant. The adjusted coefficient of determination R 2 of RA and RE is 0.797 and 0.248, respectively. Hypothesis 1 is partially supported. Table 9 represents the results of regression (2) that is the relationship between process capital and firm performance. The coefficient of MFR is negatively significant for RA (-0.103, p = 0.000) and RE (-0.266, p = 0.000). The coefficient of MFP is negatively significant for RA (-0.070, p = 0.000) and RE (-0.099, p = 0.003). The coefficient of FAT is statistically significant for RA (0.05, p = 0.005) and RE (0.053, p = 0.106).The coefficient of TAT is statistically significant for RA (0.219, p = 0.000) and RE (0.376, p = 0.000). The adjusted coefficient of determination (R 2 ) of RA and RE is 0.789 and 0.296, respectively. Hypothesis 2 is partially supported. Table 10 represents the results of regression (3) that is the relationship between innovation capital and firm performance. The coefficient of RDI is statistically significant for RA (14.77, p = 0.000) and RE (14.388, p = 0.000). The coefficient of RDP is statistically significant for RA (0.225, p = 0.019) and RE (0.273, p = 0.006). The coefficient of RDS is statistically significant for RA (0.244, p = 0.17) and RE (0.287, p = 0.007). The adjusted coefficient of determination (R 2 ) of RA and RE is 0.572 and 0.522, respectively. Hypothesis 3 is supported. Notes: **Correlation is significant at the 0.01 level (2-tailed). *Correlation is significant at the 0.05 level (2-tailed). Notes: **Correlation is significant at the 0.01 level (2-tailed). *Correlation is significant at the 0.05 level (2-tailed). Notes: **Correlation is significant at the 0.01 level (2-tailed). *Correlation is significant at the 0.05 level (2-tailed). Notes: **Correlation is significant at the 0.01 level (2-tailed). *Correlation is significant at the 0.05 level (2-tailed). Table 11 represents the results of regression (4) that is the relationship between customer capital and firm performance. The coefficient of sales expense rate (SER) is negative for RA (-0.137, p = 0.059) and RE (-0.340, p = 0.010) . The coefficient of PAR is not statistically significant for RA p = 0.69) . The coefficient of operating revenue growth rate (ORGR) is statistically significant for RA p = 0.027) , but the coefficient is negative. Hypothesis 4 is not supported. 
Conclusions
The purpose of this study is to discuss the relationship between intellectual capital and firm performance from the perspective of multimedia data applications. We use four components of intellectual capital (human capital, process capital, innovation capital, and customer capital) to investigate this issue. For human capital, it is found that ORPE and EAV increase firms' financial performance. As regards process capital, FAT and TAT is positively associated with performance. For innovation capital, it is found that R&D intensity, RDP and RDS positively affect firms' performance. Finally, for customer capital, Hypothesis 4 is not supported. From a web-scale experience from Taiwanese biotechnology and pharmaceutical industry, this paper has provided empirical evidence of intellectual and firm performance. Human capital has positive significant effect on firm performance is partially supported. Process capital has positive significant effect on firm performance is partially supported. Innovation capital has positive significant effect on firm performance is supported. Customer capital has positive significant effect on firm performance is not supported. In terms of practical implications, managers should notice that innovation capital is the most important intangible asset in biotechnology and medicine industry of Taiwan. Human capital and process capital is less important. Customer capital is not important for this industry.
Our results are subject to several caveats. One caveat pertains to our use of financial indicators, e.g., RA, RE to measure firm performance. There are other non-financial proxies can be used for future research. Second, there are several models used to measure intellectual capital, such as MVA, EVA, citation weighted patents, balanced score card and human resource accounting. Future researchers could extend our study by using other proxies as stated above.
